Trial Profile
REsPonse to Interferon-Alpha in InterfeRon-beta Neutralizing Antibody Positive Multiple Sclerosis Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon alpha (Primary) ; Interferon beta-1a; Interferon beta-1b
- Indications Multiple sclerosis
- Focus Biomarker; Pharmacodynamics
- Acronyms REPAIR
- 16 Jan 2013 Only treatment table updated, ex-Vans.
- 08 Aug 2011 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 07 Jun 2011 European Clinical trials database reports 7 Jun 2011 as global end of the trial